Literature DB >> 16738198

Gene expression profiling as a window into idiopathic pulmonary fibrosis pathogenesis: can we identify the right target genes?

Naftali Kaminski1, Ivan O Rosas.   

Abstract

Expression microarrays that provide genome-level, transcriptional, high-resolution profiles have been applied successfully to multiple diseases. Although microarrays provide information regarding thousands of genes, many investigators prefer to focus on a single gene and validate its role, an approach often supported by grant and journal reviewers. Only a minority of investigators focus on global changes in gene expression. Here, we describe and contrast two general approaches to the use of microarray data: the reductionist "cherry picking" approach and the more global, quantitative "systems" approach. We describe microarray analysis experiments relevant to idiopathic pulmonary fibrosis (IPF) in the context of these two approaches. Although it seems that the cherry-picking approaches have been successful in identifying new relevant genes in IPF, we suggest that to fulfill the discovery potential of microarrays in IPF and to create a working model of IPF, unbiased integrative systems approaches are required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738198      PMCID: PMC2658685          DOI: 10.1513/pats.200601-011TK

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  33 in total

1.  International consensus statement on idiopathic pulmonary fibrosis.

Authors:  U Costabel; T E King
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

Review 2.  From signatures to models: understanding cancer using microarrays.

Authors:  Eran Segal; Nir Friedman; Naftali Kaminski; Aviv Regev; Daphne Koller
Journal:  Nat Genet       Date:  2005-06       Impact factor: 38.330

3.  Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.

Authors:  Xiaoqing Lu; Hovav Nechushtan; Feiying Ding; Manuel F Rosado; Rakesh Singal; Ash A Alizadeh; Izidore S Lossos
Journal:  Blood       Date:  2004-12-09       Impact factor: 22.113

4.  Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis.

Authors:  F Takahashi; K Takahashi; T Okazaki; K Maeda; H Ienaga; M Maeda; S Kon; T Uede; Y Fukuchi
Journal:  Am J Respir Cell Mol Biol       Date:  2001-03       Impact factor: 6.914

5.  Genes that mediate breast cancer metastasis to lung.

Authors:  Andy J Minn; Gaorav P Gupta; Peter M Siegel; Paula D Bos; Weiping Shu; Dilip D Giri; Agnes Viale; Adam B Olshen; William L Gerald; Joan Massagué
Journal:  Nature       Date:  2005-07-28       Impact factor: 49.962

6.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

7.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.

Authors:  Andy J Minn; Yibin Kang; Inna Serganova; Gaorav P Gupta; Dilip D Giri; Mikhail Doubrovin; Vladimir Ponomarev; William L Gerald; Ronald Blasberg; Joan Massagué
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

8.  High plasma concentrations of osteopontin in patients with interstitial pneumonia.

Authors:  J Kadota; S Mizunoe; K Mito; H Mukae; S Yoshioka; K Kawakami; Y Koguchi; K Fukushima; S Kon; S Kohno; A Saito; T Uede; M Nasu
Journal:  Respir Med       Date:  2005-01       Impact factor: 3.415

9.  An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.

Authors:  Alejandro Sweet-Cordero; Sayan Mukherjee; Aravind Subramanian; Han You; Jeffrey J Roix; Christine Ladd-Acosta; Jill Mesirov; Todd R Golub; Tyler Jacks
Journal:  Nat Genet       Date:  2004-12-19       Impact factor: 38.330

10.  Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts.

Authors:  Elisabetta A Renzoni; David J Abraham; Sarah Howat; Xu Shi-Wen; Piersante Sestini; George Bou-Gharios; Athol U Wells; Srihari Veeraraghavan; Andrew G Nicholson; Christopher P Denton; Andrew Leask; Jeremy D Pearson; Carol M Black; Kenneth I Welsh; Roland M du Bois
Journal:  Respir Res       Date:  2004-11-30
View more
  35 in total

1.  A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.

Authors:  Yogesh M Kulkarni; Sucharita Dutta; Anand Krishnan V Iyer; Rajkumar Venkatadri; Vivek Kaushik; Vani Ramesh; Clayton A Wright; Oliver John Semmes; Juan S Yakisich; Neelam Azad
Journal:  Proteomics       Date:  2015-11-24       Impact factor: 3.984

Review 2.  Towards systems biology of human pulmonary fibrosis.

Authors:  Sean M Studer; Naftali Kaminski
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  Impairment of alveolar macrophage transcription in idiopathic pulmonary fibrosis.

Authors:  Ping Ren; Ivan O Rosas; Sandra D Macdonald; Hai-Ping Wu; Eric M Billings; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2007-03-01       Impact factor: 21.405

4.  Mouse Models of Lung Fibrosis.

Authors:  Olivia Mekhael; Safaa Naiel; Megan Vierhout; Aaron I Hayat; Spencer D Revill; Soumeya Abed; Mark D Inman; Martin R J Kolb; Kjetil Ask
Journal:  Methods Mol Biol       Date:  2021

5.  Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia.

Authors:  Xuyou Zhu; Xia Fang; Wei Chen; Fei Han; Ziling Huang; Benfang Luo; Pan Gu; Long Zhang; Weizhe Qiu; Yu Zeng; Weiwei Rui; Xianghua Yi
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 6.  Imaging Pulmonary Inflammation.

Authors:  Philip M Scherer; Delphine L Chen
Journal:  J Nucl Med       Date:  2016-09-01       Impact factor: 10.057

Review 7.  Bronchial blood supply after lung transplantation without bronchial artery revascularization.

Authors:  Mark R Nicolls; Martin R Zamora
Journal:  Curr Opin Organ Transplant       Date:  2010-10       Impact factor: 2.640

Review 8.  Personalized medicine: applying 'omics' to lung fibrosis.

Authors:  Jose D Herazo-Maya; Naftali Kaminski
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

Review 9.  Complement-mediated microvascular injury leads to chronic rejection.

Authors:  Mohammad A Khan; Mark R Nicolls
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF).

Authors:  Kathy Boon; Nathaniel W Bailey; Jun Yang; Mark P Steel; Steve Groshong; Dolly Kervitsky; Kevin K Brown; Marvin I Schwarz; David A Schwartz
Journal:  PLoS One       Date:  2009-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.